结直肠癌手术切口疝:Hughes 缝合随机试验
HART 多中心单盲 RCT 将 802 例结直肠癌中线切口患者随机分入 Hughes 缝合组或术者标准缝合组。1 年切口疝发生率 Hughes 组 14.8%、标准组 17.1%(OR 0.84,95%CI 0.55–1.27,P=0.402),2 年两组亦无统计学差异,但 Hughes 组手术部位感染率更高(13.2% vs 7.7%,OR 1.82,95%CI 1.14–2.91,P=0.011)。
要点
- Hughes 缝合未降低 1 年及 2 年切口疝发生率。
- Hughes 组手术部位感染率显著高于标准缝合组。
- 结直肠癌术后切口疝发生率仍较高。
核心结论
- Hughes 缝合与标准 Mass 缝合在 1 年及 2 年切口疝发生率上无统计学差异。
研究设计与样本
- 务实性多中心单盲随机对照试验,纳入 802 例结直肠癌中线切口手术患者,Hughes 组 401 例、标准组 401 例。
主要发现
- 1 年时 672 例(83.7%)完成主要结局分析,Hughes 组 339 例中 50 例(14.8%)发生切口疝,标准组 333 例中 57 例(17.1%)发生(OR 0.84,95%CI 0.55–1.27,P=0.402)。
- 2 年时 Hughes 组 78 例(28.7%)、标准组 84 例(31.8%)发生切口疝(OR 0.86,95%CI 0.59–1.25,P=0.429)。
- Hughes 组手术部位感染率 13.2%,标准组 7.7%(OR 1.82,95%CI 1.14–2.91,P=0.011),其余不良事件两组相似。
临床怎么用
- Hughes 缝合不宜作为降低结直肠癌术后切口疝的常规推荐,且需警惕手术部位感染风险增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Incisional hernias cause morbidity and may require further surgery. HART (Hughes Abdominal Repair Trial) assessed the effect of an alternative suture method on the incidence of incisional hernia following colorectal cancer surgery. METHODS: A pragmatic multicentre single-blind RCT allocated patients undergoing midline incision for colorectal cancer to either Hughes closure (double far-near-near-far sutures of 1 nylon suture at 2-cm intervals along the fascia combined with conventional mass closure) or the surgeon's standard closure. The primary outcome was the incidence of incisional hernia at 1 year assessed by clinical examination. An intention-to-treat analysis was performed. RESULTS: Between August 2014 and February 2018, 802 patients were randomized to either Hughes closure (401) or the standard mass closure group (401). At 1 year after surgery, 672 patients (83.7 per cent) were included in the primary outcome analysis; 50 of 339 patients (14.8 per cent) in the Hughes group and 57 of 333 (17.1 per cent) in the standard closure group had incisional hernia (OR 0.84, 95 per cent c.i. 0.55 to 1.27; P = 0.402). At 2 years, 78 patients (28.7 per cent) in the Hughes repair group and 84 (31.8 per cent) in the standard closure group had incisional hernia (OR 0.86, 0.59 to 1.25; P = 0.429). Adverse events were similar in the two groups, apart from the rate of surgical-site infection, which was higher in the Hughes group (13.2 versus 7.7 per cent; OR 1.82, 1.14 to 2.91; P = 0.011). CONCLUSION: The incidence of incisional hernia after colorectal cancer surgery is high. There was no statistical difference in incidence between Hughes closure and mass closure at 1 or 2 years. REGISTRATION NUMBER: ISRCTN25616490 (http://www.controlled-trials.com). After bowel cancer surgery, bulges known as hernias can occur at the site of the scar. Many patients find this uncomfortable and embarrassing. These hernias can also need further operations, sometimes as an emergency. This trial aimed to find out whether one way of closing the scars was better than another at stopping hernias developing. A total of 802 patients from 28 different hospitals in the UK joined the trial. The patients all had bowel cancer, and at the end of the operation had either a method known as the Hughes closure to close the incision or the method that the surgeon normally used. There was no difference between the two types of closure. The trial has shown that the chance of getting a hernia after a bowel cancer operation is still much higher than surgeons or patients would like.
引用
- Incisional hernia following colorectal cancer surgery according to suture technique: Hughes Abdominal Repair Randomized Trial (HART). Br J Surg. 2022. PMID: 35979802. doi:10.1093/bjs/znac198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。